针对白血二合成,以预防动脉样硬化心血管疾病
Xiaomeng Wang1, Lohendran Baskaran2, Mark Chan3
1Cardiovascular and Metabolic Disorders Program, Duke-National University of Singapore Medical School, Singapore.
Conditioning medicine
|May 27, 2024
概括
向白血素合成可以防止动脉样硬化进展. 抑制5-氧基酶 (5-LO) 和5-氧基酶激活蛋白 (FLAP) 通过减少炎症,显示出对心血管疾病的治疗潜力.
科学领域:
- 心血管科学 心血管科学
- 炎症生物学 炎症生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 动脉样性心血管疾病 (ASCVD) 是全球主要的健康负担,需要新的预防和治疗策略.
- 炎症极大地推动动脉样硬化发展和进展,使其成为血管保护的关键治疗点.
- 利可托里因,亲炎性介质,涉及到动脉瘤炎症和进展,与心血管疾病风险有遗传联系.
研究的目的:
- 审查关于心血管疾病中白血合成抑制的研究.
- 突出针对ASCVD中的白血三烯通路的治疗潜力.
主要方法:
- 临床前和早期临床研究的概述,调查白血合成抑制剂.
- 检查 leukotriene 途径组件与心血管疾病风险之间的遗传关联.
主要成果:
- 5-氧基因酶 (5-LO) 和5-氧基因酶激活蛋白 (FLAP) 的遗传突变与心血管疾病风险增加相关.
- 药理上抑制5-LO和FLAP已经在实验模型和早期人类研究中证明了预防动脉瘤形成的有效性.
结论:
- 向白细胞三烯合成是一种有前途的治疗策略,可以预防动脉瘤炎症和进展.
- 抑制5-LO和FLAP可能会改善ASCVD风险患者的治疗结果.
相关概念视频
Antiasthma Drugs: Leukotriene Modifiers
276
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
276
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
273
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
273
Adrenergic Antagonists: ɑ and β-Receptor Blockers
434
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
434
Drugs Used in Lower Respiratory Disorders: Overview
421
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
421
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
647
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
647
Antihypertensive Drugs: Types of β-Blockers
648
β receptors are classified into three subclasses: β1, β2, and β3. β1 receptors are primarily located in the heart and kidneys. When they get activated, they increase heart rate, contractility, and renin release. This process enhances blood pressure and aids in stress management. In contrast, β2 receptors are situated mainly in the lungs, blood vessels, and skeletal muscles. Upon activation, they trigger smooth muscle relaxation, causing bronchodilation and...
648


